SuperworthEditas Medicine shares outstanding EDIT
Diluted shares outstanding, averaged over each quarter, from 2015.
- Latest quarter, to Jun 30, 2026
- 119.3M
- On a year earlier
- +41.3%
- more shares
Editas Medicine had 119.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 41.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 97.3M | +18% |
| FY2024 | 82.6M | +1% |
| FY2023 | 81.7M | +19% |
| FY2022 | 68.8M | +1% |
| FY2021 | 68.4M | +10% |
| FY2020 | 62.3M | +19% |
| FY2019 | 52.2M | +9% |
| FY2018 | 48M | +13% |
| FY2017 | 42.6M | +19% |
| FY2016 | 35.7M | +1036% |
| FY2015 | 3.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 119.3M | +41% | |
| Q1 FY26 | 97.9M | +18% | |
| Q4 FY25 | 97.3M | +18% | |
| Q3 FY25 | 90.1M | +9% | |
| Q2 FY25 | 84.4M | +3% | |
| Q1 FY25 | 83.1M | +1% | |
| Q4 FY24 | 82.6M | +1% | |
| Q3 FY24 | 82.5M | +1% | |
| Q2 FY24 | 82.3M | +15% | |
| Q1 FY24 | 81.9M | +19% | |
| Q4 FY23 | 81.7M | +19% | |
| Q3 FY23 | 81.6M | +19% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Editas Medicine
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.